Setting the regulatory bar too high for cutting-edge drugs and therapies prevents life-saving breakthroughs.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The Old Guard 2's Charlize Theron reflects on the state of female-led action movies in Hollywood and why she no longer does ...

The US Dollar (USD) is ending the week on a firm note, Scotiabank's Chief FX Strategists Shaun Osborne and Eric Theoret ...

Only one in three CFOs believe now is a good time to take on more risk, down from 60% in Q1, a Deloitte survey found.

The EUR/USD pair is consolidating below the 1.1700 mark, struggling to find fresh bullish momentum amid heightened trade tensions. At the time of writing, the pair is hovering around 1.1687 during the ...

Communications-services companies ticked down amid risk aversion. Mark Zuckerberg added another big name to Meta Platforms' new "Superintelligence" AI unit, hiring a top Apple AI researcher as part of ...

Increasing defence spending will not come without reputational risk for the government, but failing to do so would imperil ...

Shares U.S. Infrastructure ETF offers diversified, low-risk exposure to U.S. infrastructure, with a balanced portfolio. Find ...

Pete Hegseth issued a memorandum to unleash "American Drone Dominance" following President Donald Trump's executive order ...

The adrenaline once tied to the unpredictability of a straight consignment has been displaced by the measured calm of a ...